11/18/2026 | Press release | Distributed by Public on 11/18/2026 13:44
Taking care of your heart could mean better cognition and brain health, according to the latest finding from the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER).
The two-year trial, funded by the Alzheimer's Association, compared the health outcomes of a structured lifestyle program to those of a self-guided program in a population of older adults at-risk for cognitive decline.
It found that the structured program led to greater improvements in heart health and metabolic risk factors. These included body mass index, diastolic blood pressure, cholesterol and triglyceride levels, and resting heart rate. Improvements in these risk factors were linked to better cognition in both groups.
"Improving heart and metabolic health risk factors is one of the pathways through which our lifestyle program improves cognition. In this study, people who showed more improvement in many of these cardiometabolic risk factors also improved the most on cognition," said UC Davis epidemiologist Rachel Whitmer, a principal investigator of U.S. POINTER.
Whitmer is the chief of the Division of Epidemiology, director of the Population Brain Health Lab and co-director of the UC Davis Alzheimer's Disease Center. She is a professor in the Departments of Public Health Sciences and of Neurology.
The structured intervention benefit was consistent for men and women, for participants younger and older than 70, and between individuals with and without the APOE4 gene that is associated with higher Alzheimer's risk. The results were reported today at the Clinical Trials on Alzheimer's Disease 2026 conference in Boston.
The U.S. POINTER is a clinical trial that enrolled 2,111 participants at five clinical sites between May 2019 and March 2023. The mean age was 68.2 years, and 68.9% of the participants were female. They were at an elevated risk for cognitive decline due to factors such as sedentary lifestyle, poor diet and heart health issues.
The participants were randomly assigned to a structured or self-guided lifestyle intervention targeting physical activity, adherence to the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet, social and cognitive engagement and health monitoring. The two interventions differed in format, support and accountability.
Initial U.S. POINTER results, published in JAMA, showed that two-year lifestyle programs improved cognition in older adults at risk of cognitive decline. These programs targeted a combination of regular physical activity, healthy nutrition, cognitive and social challenge and health monitoring.
U.S. POINTER lifestyle programs that include regular physical activity were linked to better cognition.Previous studies have linked cardiometabolic risk factors to a higher risk of cognitive decline and dementia, particularly when they are present in midlife. In U.S. POINTER, heart health and metabolic risk factors improved in both interventions over 24 months.
Compared with the self-guided group, the structured group improved more on eight of the 10 measures, with significantly greater reductions in:
The researchers did not find significant differences in systolic blood pressure and HDL cholesterol.
"We know from observational studies that these risk factors, especially in midlife, are associated with dementia risk," Whitmer said. "Now we have shown that a structured lifestyle program can change them within 24 months, that the benefit was consistent across age, APOE4 genotype and sex, and that improving them was linked to better cognition in both intervention groups."
The clinical trial is now continuing to follow the participants in U.S. POINTER Alumni Extension study. The new phase allows for four more years of observation to assess longer-term impacts of the study's interventions on cognitive health and dementia risk.
"Strengthening heart and metabolic health is linked to better cognition over the two years of this study. The important question ahead is what sustaining those changes could mean over the years to come, and the U.S. POINTER Alumni Extension study is designed to help answer it," said Heather Snyder, a U.S. POINTER principal investigator. Snyder is Alzheimer's Association senior vice president of medical and scientific relations. U.S. POINTER and the Alumni Extension are funded by the Alzheimer's Association.